Skip to content
Boost Up Blog – Lifestyle
Author:
ODDIFACT
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
August 26, 2026
ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease
May 22, 2026